- Home
- GT vs LGND Comparison
GT vs LGND Comparison
Compare GT & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GT
- LGND
- Stock Information
- Founded
- GT 1898
- LGND 1987
- Country
- GT United States
- LGND United States
- Employees
- GT N/A
- LGND 68
- Industry
- GT Automotive Aftermarket
- LGND Biotechnology: Pharmaceutical Preparations
- Sector
- GT Consumer Discretionary
- LGND Health Care
- Exchange
- GT Nasdaq
- LGND Nasdaq
- Market Cap
- GT 2.8B
- LGND 3.2B
- IPO Year
- GT N/A
- LGND 1992
- Fundamental
- Price
- GT $8.52
- LGND $166.24
- Analyst Decision
- GT Buy
- LGND Strong Buy
- Analyst Count
- GT 4
- LGND 8
- Target Price
- GT $12.13
- LGND $144.71
- AVG Volume (30 Days)
- GT 7.1M
- LGND 139.7K
- Earning Date
- GT 11-03-2025
- LGND 08-05-2025
- Dividend Yield
- GT N/A
- LGND N/A
- EPS Growth
- GT N/A
- LGND N/A
- EPS
- GT 1.47
- LGND N/A
- Revenue
- GT $18,489,000,000.00
- LGND $181,488,000.00
- Revenue This Year
- GT N/A
- LGND $18.41
- Revenue Next Year
- GT $0.51
- LGND $18.87
- P/E Ratio
- GT $5.78
- LGND N/A
- Revenue Growth
- GT N/A
- LGND 53.40
- 52 Week Low
- GT $7.79
- LGND $81.74
- 52 Week High
- GT $12.03
- LGND $129.90
- Technical
- Relative Strength Index (RSI)
- GT 40.30
- LGND 69.72
- Support Level
- GT $8.41
- LGND $161.82
- Resistance Level
- GT $8.79
- LGND $169.00
- Average True Range (ATR)
- GT 0.20
- LGND 3.61
- MACD
- GT 0.08
- LGND -0.88
- Stochastic Oscillator
- GT 44.90
- LGND 70.69
About GT The Goodyear Tire & Rubber Company
Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment. The company operates its business through three operating segments representing its regional tire businesses: Americas; Europe, the Middle East, and Africa (EMEA); and the Asia Pacific.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.